Identification of novel signal transduction proteins of importance for FLT3 signaling in acute myeloid leukemia
Novel therapeutic strategy for acute myeloid leukemia Acute myeloid leukemia, AML, is a type of blood cancer that is generally common among elder ages with median age of 65 years old. Around 350 cases per year are diagnosed with AML in Sweden. It is characterized by infiltration of cancer cells in the bone marrow leading to insufficient production of different blood cell types including the immu
